The molecular docking findings reveal that eight of Cnidium monnieri’s key active phytochemicals have protective effects on the anti-HCC core targets (EGFR, CASP3, ESR1, MAPK3, CCND1, and ERBB2). This evidence concerns the gene ESR1 and hepatocellular carcinoma.